Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects with Diabetic Macular Edema

NCT05699759 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
1
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Michelle Abou-Jaoude

Collaborators